209 related articles for article (PubMed ID: 17641826)
1. Long-term follow-up study of patients with phenylketonuria detected by the newborn screening programme in Japan.
Aoki K; Ohwada M; Kitagawa T
J Inherit Metab Dis; 2007 Aug; 30(4):608. PubMed ID: 17641826
[TBL] [Abstract][Full Text] [Related]
2. [Did the change of technique of screening investigations influence on improvement of test credibility in recognizing and differentiating diagnostics of hiperphenylalaninemias?].
Didycz B; Lemańska D; Słuszniak A
Przegl Lek; 2009; 66(1-2):11-3. PubMed ID: 19485249
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of effectiveness and outcome of PKU screening and management in the State of Sergipe, Brazil.
Ramalho AR; Ramalho RJ; Oliveira CR; Magalhães MM; Santos EG; Sarmento PM; Matos DO; Oliveira MC; Oliveira AL; Aguiar-Oliveira MH
Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):62-7. PubMed ID: 24728166
[TBL] [Abstract][Full Text] [Related]
4. Newborn phenylketonuria (PKU) Guthrie (BIA) screening and early hospital discharge.
Hanley WB; Demshar H; Preston MA; Borczyk A; Schoonheyt WE; Clarke JT; Feigenbaum A
Early Hum Dev; 1997 Jan; 47(1):87-96. PubMed ID: 9118832
[TBL] [Abstract][Full Text] [Related]
5. HPLC for confirmatory diagnosis and biochemical monitoring of Cuban patients with hyperphenylalaninemias.
Contreras J; Alonso E; Fuentes LE
MEDICC Rev; 2015 Jan; 17(1):23-8. PubMed ID: 25725765
[TBL] [Abstract][Full Text] [Related]
6. Dietary management practices in phenylketonuria across European centres.
Ahring K; Bélanger-Quintana A; Dokoupil K; Gokmen Ozel H; Lammardo AM; MacDonald A; Motzfeldt K; Nowacka M; Robert M; van Rijn M
Clin Nutr; 2009 Jun; 28(3):231-6. PubMed ID: 19362397
[TBL] [Abstract][Full Text] [Related]
7. Elevated phenylalanine on newborn screening: follow-up testing may reveal undiagnosed galactosaemia.
Shakespeare L; Downing M; Allen J; Casbolt AM; Ellin S; Maloney M; Race G; Bonham J
Ann Clin Biochem; 2010 Nov; 47(Pt 6):567-9. PubMed ID: 20947531
[TBL] [Abstract][Full Text] [Related]
8. Neonatal phenylalanine wash-out in phenylketonuria.
Porta F; Ponzone A; Spada M
Metab Brain Dis; 2020 Oct; 35(7):1225-1229. PubMed ID: 32661828
[TBL] [Abstract][Full Text] [Related]
9. Newborn screening: a national public health programme in Brazil.
de Carvalho TM; dos Santos HP; dos Santos IC; Vargas PR; Pedrosa J
J Inherit Metab Dis; 2007 Aug; 30(4):615. PubMed ID: 17694357
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients treated for phenylketonuria (PKU). Results from the Prague PKU Center.
Cechák P; Hejcmanová L; Rupp A
Eur J Pediatr; 1996 Jul; 155 Suppl 1():S59-63. PubMed ID: 8828612
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results.
Giżewska M; MacDonald A; Bélanger-Quintana A; Burlina A; Cleary M; Coşkun T; Feillet F; Muntau AC; Trefz FK; van Spronsen FJ; Blau N
Eur J Pediatr; 2016 Feb; 175(2):261-72. PubMed ID: 26350228
[TBL] [Abstract][Full Text] [Related]
12. Issues in newborn screening for phenylketonuria.
Koch RK
Am Fam Physician; 1999 Oct; 60(5):1462-6. PubMed ID: 10524490
[TBL] [Abstract][Full Text] [Related]
13. [What disorders suspect following an increase of phenylalanine on newborn screening?].
Michel MA; Raucourt E; Bednarek N; Garnotel R
Ann Biol Clin (Paris); 2014; 72(2):193-6. PubMed ID: 24736139
[TBL] [Abstract][Full Text] [Related]
14. Optimizing the Phenylalanine Cut-Off Value in a Newborn Screening Program.
Perko D; Repic Lampret B; Remec ZI; Zerjav Tansek M; Drole Torkar A; Krhin B; Bicek A; Oblak A; Battelino T; Groselj U
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328070
[TBL] [Abstract][Full Text] [Related]
15. Early blood sampling in neonatal programs for the detection of phenylketonuria.
Szeinberg A; Cohen BE
Padiatr Padol; 1982; 17(2):287-92. PubMed ID: 7099682
[TBL] [Abstract][Full Text] [Related]
16. Newborn screening 50 years later: access issues faced by adults with PKU.
Berry SA; Brown C; Grant M; Greene CL; Jurecki E; Koch J; Moseley K; Suter R; van Calcar SC; Wiles J; Cederbaum S
Genet Med; 2013 Aug; 15(8):591-9. PubMed ID: 23470838
[TBL] [Abstract][Full Text] [Related]
17. Outcome of early detected and early treated phenylketonuria patients.
Rylance G
Postgrad Med J; 1989; 65 Suppl 2():S7-9. PubMed ID: 2622815
[TBL] [Abstract][Full Text] [Related]
18. Insurance Reimbursement for Special Foods and Phenylalanine Levels in Patients With PKU in China.
Wang B; Xia Y; Cheng M; Luo H; Xue L; Gong A; Liu X; Liao G; Song J; Ning K
JAMA Netw Open; 2024 Jun; 7(6):e2412886. PubMed ID: 38837161
[TBL] [Abstract][Full Text] [Related]
19. Key European guidelines for the diagnosis and management of patients with phenylketonuria.
van Spronsen FJ; van Wegberg AM; Ahring K; Bélanger-Quintana A; Blau N; Bosch AM; Burlina A; Campistol J; Feillet F; Giżewska M; Huijbregts SC; Kearney S; Leuzzi V; Maillot F; Muntau AC; Trefz FK; van Rijn M; Walter JH; MacDonald A
Lancet Diabetes Endocrinol; 2017 Sep; 5(9):743-756. PubMed ID: 28082082
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of patients with phenylketonuria receiving tetrahydrobiopterin treatment.
Trefz FK; Scheible D; Frauendienst-Egger G
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S163-9. PubMed ID: 20217238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
